Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure

  • Cannie, Douglas E.|||0000-0001-6298-922X
  • Syrris, Petros|||0000-0002-2363-8758
  • Protonotarios, Alexandros|||0000-0001-8595-7212
  • Bakalakos, Athanasios
  • Pruny, Jean-François
  • Ditaranto, Raffaello
  • Martinez-Veira, Cristina
  • Larrañaga-Moreira, Jose M.
  • Medo, Kristen
  • Bermudez Jimenez, Francisco J.|||0000-0003-0325-7349
  • Ben Yaou, Rabah
  • Leturcq, France
  • Mezcua, Ainhoa Robles
  • Marini-Bettolo, Chiara|||0000-0003-3795-6017
  • Cabrera-Borrego, Eva|||0000-0003-2997-2391
  • Reuter, Chloe
  • Limeres Freire, Javier|||0000-0003-3644-9494
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Mestroni, Luisa
  • Taylor, Matthew R G.
  • Parikh, Victoria N.
  • Ashley, Euan A.
  • Barriales-Villa, Roberto|||0000-0002-6721-3487
  • Jiménez-Jáimez, Juan|||0000-0001-5541-898X
  • García-Pavía, Pablo|||0000-0002-5470-2257
  • Charron, Philippe|||0000-0002-1782-1118
  • Biagini, Elena|||0000-0003-0295-0440
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • Bourke, John
  • Savvatis, Konstantinos|||0000-0003-1966-1880
  • Wahbi, Karim|||0000-0001-7682-7387
  • Elliott, Perry M.|||0000-0003-3383-3984
Emery-Dreifuss muscular dystrophy (EDMD) is caused by variants in EMD (EDMD1) and LMNA (EDMD2). Cardiac conduction defects and atrial arrhythmia are common to both, but LMNA variants also cause end-stage heart failure (ESHF) and malignant ventricular arrhythmia (MVA). This study aimed to better characterize the cardiac complications of EMD variants. Consecutively referred EMD variant-carriers were retrospectively recruited from 12 international cardiomyopathy units. MVA and ESHF incidences in male and female variant-carriers were determined. Male EMD variant-carriers with a cardiac phenotype at baseline (EMD ) were compared with consecutively recruited male LMNA variant-carriers with a cardiac phenotype at baseline (LMNA ). Longitudinal follow-up data were available for 38 male and 21 female EMD variant-carriers [mean (SD) ages 33.4 (13.3) and 43.3 (16.8) years, respectively]. Nine (23.7%) males developed MVA and five (13.2%) developed ESHF during a median (inter-quartile range) follow-up of 65.0 (24.3-109.5) months. No female EMD variant-carrier had MVA or ESHF, but nine (42.8%) developed a cardiac phenotype at a median (inter-quartile range) age of 58.6 (53.2-60.4) years. Incidence rates for MVA were similar for EMD and LMNA (4.8 and 6.6 per 100 person-years, respectively; log-rank P =.49). Incidence rates for ESHF were 2.4 and 5.9 per 100 person-years for EMD and LMNA , respectively (log-rank P =.09). Male EMD variant-carriers have a risk of progressive heart failure and ventricular arrhythmias similar to that of male LMNA variant-carriers. Early implantable cardioverter defibrillator implantation and heart failure drug therapy should be considered in male EMD variant-carriers with cardiac disease.